757 results about "Cochlea" patented technology

The invention comprises a totally implantable hearing prosthesis for hearing impaired persons. An inertial vibrational element is hermetically sealed and implanted in bone between the lateral and superior semicircular canals without breaching the integrity of the canals. The vibrational element is adapted to vibrate the walls of the canals and the fluids contained therein, thereby vibrating contiguous fluids within the cochlea thus stimulating hair cells and creating a hearing percept. The invention can also be adapted to be a tinnitus masking system, and/or used in combination with a coehlear implant hearing system.

Systems and methods for utilizing inter-microphone level differences (ILD) to attenuate noise and enhance speech are provided. In exemplary embodiments, primary and secondary acoustic signals are received by omni-directional microphones, and converted into primary and secondary electric signals. A differential microphone array module processes the electric signals to determine a cardioid primary signal and a cardioid secondary signal. The cardioid signals are filtered through a frequency analysis module which takes the signals and mimics a cochlea implementation (i.e., cochlear domain). Energy levels of the signals are then computed, and the results are processed by an ILD module using a non-linear combination to obtain the ILD. In exemplary embodiments, the non-linear combination comprises dividing the energy level associated with the primary microphone by the energy level associated with the secondary microphone. The ILD is utilized by a noise reduction system to enhance the speech of the primary acoustic signal.

The present invention relates to a device for picking up biological electrical signals, and more precisely auditory evoked potentials generated by acoustic and/or electrical and/or mechanical stimulation of the cochlear, or of a portion of the auditory system in man or animal. The implantable device for measuring or picking up auditory evoked potentials comprises at least two extracochlear pickup electrodes connected to the inputs of a differential amplifier.

A drug administration system configured to administer a drug to a user's ear includes a housing, sized and shaped to substantially fit behind the user's ear, and configured to pump the drug in controlled amounts to the user's middle ear. A drug reservoir is disposed in the housing and includes a drug configured to treat an inner ear condition. A catheter is operatively coupled to the drug reservoir and is sized and shaped to extend from the drug administration unit into the user's middle ear.

A multichannel cochlear implant system spatially spreads the excitation pattern in the target neural tissue by either: (1) rapid sequential stimulation of a small group of electrodes, or (2) simultaneously stimulating a small group of electrodes. Such multi-electrode stimulation stimulates a greater number of neurons in a synchronous manner, thereby increasing the amplitude of the extra-cellular voltage fluctuation and facilitating its recording. The electrical stimuli are applied simultaneously (or sequentially at a rapid rate) on selected small groups of electrodes while monitoring the evoked compound action potential (ECAP) on a nearby electrode. The presence of an observable ECAP not only validates operation of the implant device at a time when the patient may be unconscious or otherwise unable to provide subjective feedback, but also provides a way for the magnitude of the observed ECAP to be recorded as a function of the amplitude of the applied stimulus. From this data, a safe, efficacious and comfortable threshold level can be obtained which may be used thereafter as the initial setting of the stimulation parameters of the neurostimulation device, or to guide the setting of the stimulation parameters of the neurostimulation device.

An implantable electrode system, adapted for insertion into a cochlea, includes an elongate electrode array stored within a sheath. The electrode array has a multiplicity of electrode contacts carried on a flexible elongate carrier, which carrier is adapted for insertion into one of the spiraling ducts, e.g., the scala tympani, of the cochlea, and further has longitudinal channel or lumen that passes therethrough. 3-6 mm from the distal end of the electrode array. To insert the electrode system into the cochlea, a stylet wire is inserted into the channel or lumen of the electrode array while the electrode array is held within the sheath. The sheath is then removed, and the electrode array is then gently guided and pushed through a cochleostomy into the cochlea by extending the stylet wire to a desired depth. As the electrode array is thus inserted into the cochlea, the stylet wire is retracted and the electrode array remains implanted within the cochlea.

An intra-cochlear implant is provided for aiding in the hearing of a patient. The implant includes a body portion implantable within an interior of a cochlea of a patient. The body portion has a proximal end, a distal end and a primary axis. A plurality of signal carrying electrodes extends along the body portion. The electrodes have proximal ends and distal ends, with the proximal ends being capable of receiving a signal from a signal generator, and the distal ends being capable of delivering the received signal to an anatomical receptor within a cochlea. At least several of the plurality of electrodes have a nanoelectrode-sized portion. The implant also may include a fluid delivery system of tubules, reservoirs, and pumps for the delivery of chemicals and cells to activate regeneration of neural elements lost during the hearing loss process.

A method for fitting a cochlear prosthesis to a cochlea having residual acoustic hearing capability, in order to exploit the residual acoustic hearing capability to the extent possible. A portion of the cochlea having residual acoustic hearing capability is determined by measuring the neural response to acoustic and/or electrical stimulations. Electrical stimulations are applied only to the portions of the cochlea lacking acoustic hearing capability, or possessing only partial acoustic hearing capability. Surgical implantation depth may be optimised by the method, and/or a patient map may be suitably defined to implement the method.

Devices for the delivery of a bioactive substance to a cochlea and methods of delivery thereof. The devices include means to allow the release of the bioactive substance within a cochlea.

An implantable component (30) of a cochlear implant system comprising a housing for a stimulator unit (31) that is adapted to output one or more stimulation signals and an electrode assembly (30) adapted to apply electrical stimulation in accordance with the output of the stimulator unit (31). On implantation, the housing is positionable such that the electrode assembly (20) extends from the housing at least initially in a downward orientation toward the mastoid cavity before entering the cochlea. An external component (50, 60 or 70) of a cochlear implant system comprising a support for mounting to the ear of an recipient and an external signal transmitter coil (53) wherein the signal transmitter coil (53) is movably mounted to at least a portion of the support.

A cochlear stimulation lead and method of making an aggressively curved electrode array are provided. In one embodiment of the lead, while the curved section of the lead is curled further beyond the originally molded curvature and held in this position, a filling channel is filled up with a filling material that is hardened or cured in this held position. The resulting lead has a tip curvature that is more curved than the originally molded curvature.

An at least partially implantable system for rehabilitation of a hearing disorder with at least one acoustic sensor (microphone) for picking up an acoustic sensor signal and converting the acoustic sensor signal into corresponding electrical signals, an electronic signal processing unit for audio signal processing and amplification, an electrical power supply unit which supplies individual components of the system with energy, and an output-side actuator stimulation arrangement, the actuator stimulation arrangement has a dual intracochlear arrangement in combination with a stimulator arrangement with at least one stimulator element for at least indirect mechanical stimulation of a damaged inner ear and one electrically acting stimulation electrode arrangement with at least one cochlear implant electrode for electrical stimulation of the inner ear.

A cochlear implant system, or other neural stimulation system, has the capability to stimulate fast enough to induce stochastic neural firing so as to restore “spontaneous” neural activity. The stimulation rate applied to the more distally-located electrodes of an electrode array connected to the implant system is reduced from the stimulation rate applied to the more proximally-located electrodes. Thus, in the case of a cochlear implant system, the apically-located regions within the cochlea are stimulated at a reduced rate in order to conserve power. Pulse widths of the reduced-rate pulses may further be increased, and amplitudes reduced, to further conserve power. As needed, a low-level random conditioner stimulation signal may be applied to the apical regions of the cochlea in order to ensure the occurrence of random neural firings.

A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and/or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.

This method of determining an intracochlea tissue impedance comprises using at least two stimulating electrodes to apply an electrical stimulus to intracochlea tissue. A voltage caused by the stimulus is measured between two measuring electrodes distinct from the stimulating electrodes. From the voltage a stimulus-response characteristic of tissue between the two measuring electrodes is determined. This allows the tissue/electrode interface impedance and potential and the tissue impedance and potential to be uniquely determined. In turn, modiolus currents can be estimated in monopolar stimulation mode. Also provided is automated initiation of re-mapping of the device when tissue characteristics change

The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The tinnitus to be prevented and/or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, sudden deafness, or other cochlear excitotoxic-inducing occurrence.

An insertion tool uses a stylet wire to help guide an electrode system into a cochlea. The insertion tool includes three main elements or parts: a handle, a guide and a slider. The handle is made from light stainless steel tube flattened in front with a machined slot. The guide consists of a plurality of metal tubes, fixed to each other within a holding bracket. In one embodiment, the slider includes a stabilizer wire, a long stylet wire, and a short stylet wire. During the assembly process, the stabilizer and stylet wires are inserted into respective tubes of the guide and the end of the stabilizer wire is bent to form an offset. The electrode system is loaded onto the tool by inserting the short stylet wire into a holder that supports the electrode lead.